WisdomTree BioRevolution UCITS ETF AccumUSDWisdomTree BioRevolution UCITS ETF AccumUSDWisdomTree BioRevolution UCITS ETF AccumUSD

WisdomTree BioRevolution UCITS ETF AccumUSD

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪4.79 M‬EUR
Fund flows (1Y)
‪2.20 M‬EUR
Dividend yield (indicated)
Discount/Premium to NAV
−0.5%
Shares outstanding
‪309.86 K‬
Expense ratio
0.45%

About WisdomTree BioRevolution UCITS ETF AccumUSD


Brand
WisdomTree
Home page
Inception date
Dec 3, 2021
Structure
Irish VCIC
Index tracked
WisdomTree BioRevolution Index
Replication method
Physical
Management style
Passive
Dividend treatment
Capitalizes
Primary advisor
Irish Life Investment Managers Ltd.
ISIN
IE000O8KMPM1
Functions as an open-end investment fund

Classification


Asset Class
Equity
Category
Sector
Focus
Theme
Niche
Genomic advancements
Strategy
Vanilla
Geography
Global
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of August 29, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.91%
Health Technology81.60%
Health Services6.60%
Process Industries6.44%
Technology Services2.65%
Consumer Non-Durables1.52%
Electronic Technology1.11%
Bonds, Cash & Other0.09%
Cash0.09%
Stock breakdown by region
0.3%80%18%1%
North America80.16%
Europe18.42%
Asia1.15%
Oceania0.27%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


WDNA invests in stocks. The fund's major sectors are Health Technology, with 81.60% stocks, and Health Services, with 6.60% of the basket. The assets are mostly located in the North America region.
WDNA top holdings are Ginkgo Bioworks Holdings, Inc. Class A and Intellia Therapeutics, Inc., occupying 3.18% and 3.07% of the portfolio correspondingly.
WDNA assets under management is ‪4.79 M‬ EUR. It's risen 11.29% over the last month.
WDNA fund flows account for ‪2.20 M‬ EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, WDNA doesn't pay dividends to its holders.
WDNA shares are issued by WisdomTree, Inc. under the brand WisdomTree. The ETF was launched on Dec 3, 2021, and its management style is Passive.
WDNA expense ratio is 0.45% meaning you'd have to pay 0.45% of your investment to help manage the fund.
WDNA follows the WisdomTree BioRevolution Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
WDNA invests in stocks.
WDNA price has risen by 1.62% over the last month, and its yearly performance shows a −19.12% decrease. See more dynamics on WDNA price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −0.72% over the last month, showed a 13.22% increase in three-month performance and has decreased by −18.51% in a year.
WDNA trades at a premium (0.54%) meaning the ETF is trading at a higher price than the calculated NAV.